Le Lézard
Classified in: Tourism and vacations, Health
Subject: AWD

Australian Scientists Honoured with the Grand Hamdan Award


DUBAI, UAE, Nov. 24, 2022 /PRNewswire/ -- The Award ceremony of the Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, hosted in Dubai, took place  on 23rd of November the Museum of the Future. The Award celebrated its 12th term (2021-2022) and 22nd year, in the presence of Sheikh Rashid bin Hamdan bin Rashid Al Maktoum, who personally awarded the 14 winners.

Prof. Ian Hector Frazer and Late Dr. Jian Zhou were awarded with the prestigious Grand Hamdan Award in the field of Infectious Diseases.

Co-winner-1

Prof. Ian Hector Frazer is a Professor at the Faculty of Medicine at the University of Queensland. He is the founding CEO and Director of Research of the Translational Research Institute, Chair of the Translational Research Institute (TRI) Foundation Board, and Advisor on Medical Research, University of Queensland, Brisbane Australia.

Co-winner-2

Late Dr. Jian Zhou was the Lion Principal Research Fellow, and Chair of the HPV Structure Protein Laboratory at the Centre for Immunology and Cancer Research of the University Of Queensland Faculty of Medicine, Brisbane, Australia.

Both researchers are co-developers of the HPV (Human Papilloma Virus) vaccine that prevents infection with HPV strains responsible for the majority of cases of cervical cancer. In August 2006, Prof. Ian Frazer administered the first dose of the vaccine.

Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences is a non-profit organization that honors researchers worldwide who carry out distinguished medical research to serve humanity. The Award also stimulates scientific interaction and enriches scientific research among doctors in the UAE and overseas. 


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: